At the optimum time, anti-VEGF treatment induces sufficient vascular normalization to ensure that enough CAR-T cells can infiltrate the tumor to maintain the normalization and simultaneously exert cytotoxic effects. The gene discussed is VEGFA; the disease is neoplasm.